Evaluation of Bacillus subtilis SPB1 biosurfactant effects on hyperglycemia, angiotensin I-converting enzyme (ACE) activity and kidney function in rats fed on high-fat–high-fructose diet

References

• Anari R, Amani R, Latifi SM, et al. (2016). Association of obesity with hypertension and dyslipidemia in type 2 diabetes mellitus subjects. Diabetes Metab Syndr, S1871-402130133–3. [Epub ahead of print]. doi: 10.1016/j.dsx.2016.07.004
   Web of Science ®Google Scholar
• Anderson S, Brenner BM. (1988). Pathogenesis of diabetic glomerulopathy: Hemodynamic considerations. Diabetes Metab Rev, 4:163–77
   PubMed Web of Science ®Google Scholar
• Barton M, Carmona R, Ortmann J, et al. (2003). Obesity-associated activation of angiotensin and endothelin in the cardiovascular system. Int J Biochem Cell Biol, 35:826–37
   PubMed Web of Science ®Google Scholar
• Björck S, Nyberg G, Mulec H, et al. (1986). Beneficial effects of angiotensin converting enzyme inhibition on renal function in patients withdiabetic nephropathy. Br Med J, 293:471–4
   PubMed Web of Science ®Google Scholar
• Bray GA, Nielsen SJ, Popkin BM. (2004). Consumption of high-fructose corn syrup in beverages may play a role in the epidemic of obesity. Am J Clin Nutr, 79:537–43
   PubMed Web of Science ®Google Scholar
• Castro MC, Massa ML, Arbeláez LG, et al. (2015). Fructose-induced inflammation, insulin resistance and oxidative stress: A liver pathological triad effectively disrupted by lipoic acid. Life Sci, 137:1–6
   PubMed Web of Science ®Google Scholar
• Ceriello A, Motz E. (2004). Is oxidative stress the pathogenic mechanism underlying insulin resistance, diabetes, and cardiovascular disease? The common soil hypothesis revisited. Arterioscler Thromb Vasc Biol, 24:816–23
   PubMed Web of Science ®Google Scholar
• Council of European Communities. (1986). Council instructions about the protection of living animals used in scientific investigations. Off J Eur Commun, 358:1–28. JO86609CEE
   Google Scholar
• Daneschvar HL, Aronson MD, Smetana GW. (2016). FDA-approved anti-obesity drugs in the United States. Am J Med, 129:879.e1–.e6
   Web of Science ®Google Scholar
• Dexter AF, Middelberg APJ. (2008). Peptides as functional surfactants. Indus Eng Chem Res, 47:6391–8
   Web of Science ®Google Scholar
• Gan P, Jin D, Zhao X, et al. (2016). Bacillus-produced surfactin attenuates chronic inflammation in atherosclerotic lesions of ApoE(−/−) mice. Int Immunopharmacol, 35:226–34
   PubMed Web of Science ®Google Scholar
• Gao Z, Zhao X, Yang T, et al. (2014). Immunomodulation therapy of diabetes by oral administration of a surfactin lipopeptide in NOD mice. Vaccine, 32:6812–919
   PubMed Web of Science ®Google Scholar
• Ghribi D, Abdelkefi-Mesrati L, Mnif I, et al. (2012). Investigation of antimicrobial activity and statistical optimization of Bacillus subtilis SPB1 biosurfactant production in solid-state fermentation. J Biomed Biotechnol, 373682. doi:10.1155/2012/373682
   PubMedGoogle Scholar
• Ghribi D, Ellouze-Chaabouni S. (2011). Enhancement of Bacillus subtilis lipopeptide biosurfactants production through optimization of medium composition and adequate control of aeration. Biotechnol Res Int, 653654. doi:10.4061/2011/653654
   PubMedGoogle Scholar
• Gudiña EJ, Rangarajan V, Sen R, Rodrigues LR. (2013). Potential therapeutic applications of biosurfactants. Trends Pharmacol Sci, 34:667–75
   PubMed Web of Science ®Google Scholar
• Hamden K, Carreau S, Boujbiha MA, et al. (2008). Hyperglycaemia, stress oxidant, liver dysfunction and histological changes in diabetic male rat pancreas and liver: Protective effect of 17 beta-estradiol. Steroids, 73:495–501
   PubMed Web of Science ®Google Scholar
• Hamden K, Keskes H, Belhaj S, et al. (2011). Inhibitory potential of omega-3 fatty and fenugreek essential oil on key enzymes of carbohydrate-digestion and hypertension in diabetes rats. Lipids Health Dis, 10:226. doi:10.1186/1476-511X-10-226
   PubMed Web of Science ®Google Scholar
• Holmquist B, Bünning P, Riordan JF. (1979). A continuous spectrophotometric assay for angiotensin converting enzyme. Anal Biochem, 95:540–8
   PubMed Web of Science ®Google Scholar
• Hommel E, Parving HH, Mathiesen E, et al. (1986). Effect of captopril on kidney function in insulin-dependent diabetic patients with nephropathy. Br Med J (Clin Res Ed), 293:467–70
   PubMed Web of Science ®Google Scholar
• Joffres MR, Reed DM, Yano K. (1987). Relationship of magnesium intake and other dietary factors to blood pressure: The Honolulu heart study . Am J Clin Nutr, 45:469–75
   PubMed Web of Science ®Google Scholar
• Johnson RJ, Segal MS, Sautin Y, et al. (2007). Potential role of sugar (fructose) in the epidemic of hypertension, obesity and the metabolic syndrome, diabetes, kidney disease, and cardiovascular disease. Am J Clin Nutr, 86:899–906
   PubMed Web of Science ®Google Scholar
• Kim K, Jung SY, Kim LDK, et al. (1988). Suppression of inflammatory responses by surfactin, a selective inhibitor of platelet cytosolic phospholipase A2. Biochem Pharmacol, 55:975–85
   Web of Science ®Google Scholar
• Kopelman PG. (2000). Obesity as a medical problem. Nature, 404:635–43
   PubMed Web of Science ®Google Scholar
• Krolewski AS, Canessa M, Warram JH, et al. (1988). Predisposition to hypertension and susceptibility to renal disease in insulin-dependent diabetes mellitus. N Engl J Med, 318:140–5
   PubMed Web of Science ®Google Scholar
• Kugler AJ, Fabbio KL, Pham DQ, Nadeau DA. (2015). Inhaled technosphere insulin: A novel delivery system and formulation for the treatment of types 1 and 2 diabetes mellitus. Pharmacotherapy, 35:298–314
   PubMed Web of Science ®Google Scholar
• Mauer SM, Steffes MW, Azar S, et al. (1978). The effects of Goldblatt hypertension on development of the glomerular lesions of diabetes mellitus in the rat. Diabetes, 27:738–44
   PubMed Web of Science ®Google Scholar
• Mittenbühler K, Loleit M, Baier W, et al. (1997). Drug specific antibodies: T-cell epitope-lipopeptide conjugates are potent adjuvants for small antigens in vivo and in vitro. Int J Immunopharmacol, 19:277–87
   PubMed Web of Science ®Google Scholar
• Mnafgui K, Derbali A, Sayadi S, et al. (2015). Anti-obesity and cardioprotective effects of cinnamic acid in high fat diet-induced obese rats. J Food Sci Technol, 52:4369–77
   PubMed Web of Science ®Google Scholar
• Mnafgui K, Hamden K, Ben Salah H, et al. (2012). Inhibitory activities of Zygophyllum album: A natural weight-lowering plant on key enzymes in high-fat diet-fed rats. Evid Based Complement Alternat Med, 2012:620384. doi:10.1155/2012/620384
   PubMed Web of Science ®Google Scholar
• Mnif I, Ellouze-Chaabouni S, Ghribi D. (2012). Response surface methodological approach to optimize the nutritional parameters for enhanced production of lipopeptide biosurfactant in submerged culture by B. subtilis SPB1. JASR, 3:87–94
   Google Scholar
• Mnif I, Grau-Campistany A, Coronel-León J, et al. (2016). Purification and identification of Bacillus subtilis SPB1 lipopeptide biosurfactant exhibiting antifungal activity against Rhizoctonia bataticola and Rhizoctonia solani. Environ Sci Pollut Res Int, 23:6690–9
   PubMed Web of Science ®Google Scholar
• Mogensen CE. (1982). Long-term antihypertensive treatment inhibiting progression ofdiabetic nephropathy. Br Med J, 285:685–8
   PubMed Web of Science ®Google Scholar
• Mogensen CE. (1976). Renal function changes in diabetes. Diabetes, 25:872–9
   PubMed Web of Science ®Google Scholar
• Mude RN, Somesula SR, Adi PJ, Matcha B. (2012). Diabetic regulation through blood constituents’ modulations on treatment with Aloe vera in alloxan indiced diabetic rats. Dig J Nanomater Biostruct, 7:649–955
   Web of Science ®Google Scholar
• Nasri R, Abdelhedi O, Jemil I, et al. (2015). Ameliorating effects of goby fish protein hydrolysates on high-fat–high-fructose diet-induced hyperglycemia, oxidative stress and deterioration of kidney function in rats. Chem Biol Interact, 242:71–80
   PubMed Web of Science ®Google Scholar
• Ozbek E. (2012). Induction of oxidative stress in kidney. Int J Nephrol, 7:649–55
   Google Scholar
• Parving HH, Andersen AR, Smidt UM, et al. (1983). Diabetic nephropathy and arterial hypertension. Diabetologia, 24:10–12
   PubMed Web of Science ®Google Scholar
• Patel D. (2015). Pharmacotherapy for the management of obesity. Metab Clin Exp, 64:1376–85
   PubMed Web of Science ®Google Scholar
• Rabasa-Lhoret R, Chiasson JL. (2004). International textbook of diabetes mellitus, vol 1, 3rd ed. UK: John Wiley and Sons Ltd, 901–14
   Google Scholar
• Rosenson RS, Hurt-Camejo E. (2012). Phospholipase A2 enzymes and the risk of atherosclerosis. Eur Heart J, 33:2899–909
   PubMed Web of Science ®Google Scholar
• Sacks FM, Willett WC, Smith A, et al. (1998). Effect on blood pressure of potassium, calcium, and magnesium in women with low habitual intake. Hypertension, 31:131–8
   PubMed Web of Science ®Google Scholar
• Sahnoun R, Mnif I, Fetoui H, et al. (2014). Evaluation of Bacillus subtilis SPB1 lipopeptide biosurfactant toxicity towards mice. Int J Pept Res Ther, 20:333–40
   Web of Science ®Google Scholar
• Santos EL, de Picoli Souza K, da Silva ED, et al. (2009). Long term treatment with ACE inhibitor enalapril decreases body weight gain and increases life span in rats. Biochem Pharmacol, 78:951–8
   PubMed Web of Science ®Google Scholar
• Tarantino G, Di Minno MN, Capone D. (2009). Drug-induced liver injury: Is it somehow foreseeable? World J Gastroenterol, 15:2817–33
   PubMed Web of Science ®Google Scholar
• Zouari R, Ben Abdallah-Kolsi R, Hamden K, et al. (2015). Assessment of the antidiabetic and antilipidemic properties of Bacillus subtilis SPB1 biosurfactant in alloxan-induced diabetic rats. Biopolymers, 104:764–74
   PubMed Web of Science ®Google Scholar
• Zouari R, Hamden K, Feki AE, et al. (2016). Protective and curative effects of Bacillus subtilis SPB1 biosurfactant on high-fat–high-fructose diet induced hyperlipidemia, hypertriglyceridemia and deterioration of liver function in rats. Biomed Pharmacother, 84:323–9
   PubMed Web of Science ®Google Scholar